Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Therapies ◽

Dose Combination ◽

Faculty Opinions recommendation of Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3447957.3171054 ◽

2010 ◽

Author(s):

Takahiko Nakagawa

Keyword(s):

High Risk ◽

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Therapies ◽

Dose Combination ◽

Faculty Opinions recommendation of Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3447957.3143056 ◽

2010 ◽

Author(s):

Luis Ruilope ◽

Jose Antonio García Donaire

Keyword(s):

High Risk ◽

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Therapies ◽

Dose Combination ◽

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

Yearbook of Cardiology ◽

10.1016/j.ycar.2011.01.116 ◽

2011 ◽

Vol 2011 ◽

pp. 73-76

Author(s):

W.J. Elliott

Keyword(s):

High Risk ◽

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Therapies ◽

Dose Combination ◽

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

BMJ ◽

10.1136/sbmj.g4217 ◽

2014 ◽

pp. g4217

Author(s):

Anita Jain

Keyword(s):

Cardiovascular Disease ◽

Primary Care ◽

Risk Factor ◽

High Risk ◽

Controlled Trial ◽

Fixed Dose ◽

Risk Factor Control ◽

Dose Combination ◽

IDDF2018-ABS-0004 Efficacy and safety of fixed dose combination of drotaverine hydrochloride (80 mg) and paracetamol (500 mg) alone in amelioration of abdominal pain in patients with acute infectious gastroenteritis: a randomised controlled trial

10.1136/gutjnl-2018-iddfabstracts.1 ◽

2018 ◽

Author(s):

Shiva Narang ◽

Jitender Koli

Keyword(s):

Abdominal Pain ◽

Controlled Trial ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Efficacy And Safety ◽

Infectious Gastroenteritis ◽

Dose Combination ◽

Drotaverine Hydrochloride ◽

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

BMJ ◽

10.1136/bmj.g3318 ◽

2014 ◽

Vol 348 (may27 11) ◽

pp. g3318-g3318 ◽

Cited By ~ 93

Author(s):

V. Selak ◽

C. R. Elley ◽

C. Bullen ◽

S. Crengle ◽

A. Wadham ◽

...

Keyword(s):

Cardiovascular Disease ◽

Primary Care ◽

Risk Factor ◽

High Risk ◽

Controlled Trial ◽

Fixed Dose ◽

Risk Factor Control ◽

Dose Combination ◽

Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial

npj Primary Care Respiratory Medicine ◽

10.1038/s41533-017-0032-z ◽

2017 ◽

Vol 27 (1) ◽

Cited By ~ 6

Author(s):

Janine Pilcher ◽

Mitesh Patel ◽

Alison Pritchard ◽

Darmiga Thayabaran ◽

Stefan Ebmeier ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Secondary Analysis ◽

Beta Agonist ◽

Medical Review ◽

Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial

The Lancet Neurology ◽

10.1016/s1474-4422(18)30128-5 ◽

2018 ◽

Vol 17 (6) ◽

pp. 509-518 ◽

Cited By ~ 31

Author(s):

Bum Joon Kim ◽

Eun-Jae Lee ◽

Sun U Kwon ◽

Jong-Ho Park ◽

Yong-Jae Kim ◽

...

Keyword(s):

High Risk ◽

Ischaemic Stroke ◽

Cardiovascular Events ◽

Controlled Trial ◽

Cerebral Haemorrhage ◽

Asian Patients ◽

Faculty Opinions recommendation of Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717961928.793466541 ◽

2012 ◽

Author(s):

Jan Amlie

Keyword(s):

Atrial Fibrillation ◽

Controlled Trial ◽

Secondary Analysis ◽

Efficacy And Safety ◽

Patient Risk ◽

Faculty Opinions recommendation of Acupuncture, counselling or usual care for depression and comorbid pain: secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718373453.793494739 ◽

2014 ◽

Author(s):

Mike Cummings

Keyword(s):

Usual Care ◽

Controlled Trial ◽

Secondary Analysis ◽